126811-29-8

Basic information

• Product Name: 4-CHLORO-7-BROMOINDOLE
• Synonyms: 4-CHLORO-7-BROMOINDOLE;1H-Indole, 7-broMo-4-chloro-;7-Bromo-4-chloroindole
• CAS NO: 126811-29-8
• Molecular Formula: C₈H₅BrClN
• Molecular Weight: 230.5
• Mol File: 126811-29-8.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 345.8±22.0 °C(Predicted)
• Appearance: /
• Density: 1.772±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 14.43±0.30(Predicted)
• CAS DataBase Reference: 4-CHLORO-7-BROMOINDOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CHLORO-7-BROMOINDOLE(126811-29-8)
• EPA Substance Registry System: 4-CHLORO-7-BROMOINDOLE(126811-29-8)

Safety Data

• Hazardous Substances Data: 126811-29-8(Hazardous Substances Data)

Usage

General Description

4-Chloro-7-Bromindole is a chemical compound used frequently as a base material in the production of various types of pharmacological and chemical products. Its structure consists of an indole core, characterized by a benzene ring fused to a pyrrole ring, with chlorine and bromine substituents at the 4 and 7 positions respectively. This organic compound is usually manipulated in a laboratory setting and it is potentially hazardous, requiring appropriate safety measures for handling and use. It plays a significant role in research and development in the pharmaceutical industry, specifically in the synthesis of new drugs.

Upstream product

• 41513-04-6 2-chloro-5-bromonitrobenzene 
• 1826-67-1 vinyl magnesium bromide 

Downstream Products

• 875305-77-4 4-chloro-1H-indole-7-carboxylic acid 
• 1169857-84-4 C₃₃H₄₃ClN₂O₃Si 
• 165669-23-8 N-(3,4-dichloro-1H-indole-7-yl)-4-nitrobenzenesulfonamide 
• 292635-70-2 N-(4-chloro-1H-indol-7-yl)-4-nitro-benzenesulfonamide 
• 292635-80-4 N-(4-chloro-1H-indol-7-yl)-4-cyano-benzenesulfonamide 
• 292636-12-5 4-chloro-7-aminoindole 

Relevant articles and documents

Ether compound and pharmaceutical application thereof in prevention and treatment of diabetes and metabolic syndrome

The invention relates to an ether compound and a pharmaceutical application thereof in prevention and treatment of diabetes and metabolic syndrome. Specifically, the invention provides a compound as shown in a formula (I), an isomer, a raceme, a prodrug, a solvate, a deuterated substance or a pharmaceutically acceptable salt thereof, and Ar1, Ar2, X, Y and R are defined in the specification.

ORGANIC COMPOUNDS AND ORGANIC ELECTRO LUMINESCENCE DEVICE COMPRISING THE SAME

The present invention relates to a novel organic compound which can be used as a material for an organic electroluminescent element, and an organic electroluminescent element comprising the compound.

HEPATITIS C VIRUS INHIBITORS

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment o